loader
Please Wait
Applying Filters...

Seqens Seqens

X

Information, Expiry & Status of FDA Orange Book Patents covering Ambrisentan

Client Email Product
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 GILEAD (6)

filter

01 8377933 (2)

02 9474752 (2)

03 9549926 (2)

filter

01 Blank (6)

filter

01 Blank (6)

filter

01 2027-12-11 (4)

02 2031-10-14 (2)

URL Supplier Web Content
9474752
2027-12-11
U-1754
22081
FOR THE TREATMENT OF PULMONARY HYPERTENSION (PAH) IN COMBINATION WITH TADALAFIL
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
9474752
2027-12-11
U-1754
22081
FOR THE TREATMENT OF PULMONARY HYPERTENSION (PAH) IN COMBINATION WITH TADALAFIL
2
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
9549926
2031-10-14
U-1965
22081
2
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
8377933
2027-12-11
U-1754
22081
FOR THE TREATMENT OF PULMONARY HYPERTENSION (PAH) IN COMBINATION WITH TADALAFIL
2
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
8377933
2027-12-11
U-1754
22081
FOR THE TREATMENT OF PULMONARY HYPERTENSION (PAH) IN COMBINATION WITH TADALAFIL
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
9549926
2031-10-14
U-1965
22081
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Post Enquiry
POST ENQUIRY